Navigation Links
Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
Date:2/9/2011

MORRISTOWN, N.J., Feb. 9, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252 (the "'252 Patent").

The Company said it is continuing to seek final FDA approval of the products.

In 2009, Reckitt Benckiser sued Watson Laboratories, Inc. for patent infringement related to the generic versions of Mucinex®.  The Mucinex® products had total U.S. sales of approximately $500 million for the twelve months ending December 31, 2010, according to IMS Health and IRI and are indicated to help loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.  

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a leading global specialty pharmaceutical company.  The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health.  Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement Statements contained in this press release that refer to non-historical facts are forward-looking statements that reflect Watson's current perspective of existing information as of the date of this release.  It is important to note tha
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2010 Earnings
2. Watson Confirms Welchol® Oral Suspension Patent Challenge
3. Watson Presents Outlook for Continued Long Term Growth
4. Reportlinker Adds Watson Pharmaceuticals Inc.: PharmaVitae Profile
5. Watson Announces Preliminary Financial Performance for FY 2010
6. Watson to Host Investor Day on January 21 in New York City
7. Watsons Generic Fentora® Receives FDA Approval
8. Watson to Present at the 29th Annual JP Morgan Healthcare Conference
9. Watson Announces Novel Oral Contraceptive Approval
10. Watson and Richter Announce Exclusive License Agreement for Esmya™
11. Watson Confirms Exalgo™ Patent Challenge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...  The board of directors of VirtualScopics, Inc. (NASDAQ: ... trial imaging solutions, today announced that James Groff ... immediately.  Mr. Groff has held the role of acting ... in January 2006 as an accounting manager and was ... the board of VirtualScopics asked Jim to assume the ...
(Date:8/21/2014)... Aug. 21, 2014  SI-BONE, Inc. ( San ... pioneered the use of the iFuse Implant System, ® ... fusion of the sacroiliac (SI) joint, announced that Priority ... to its Lumbar Fusion Medical Policy No. 91590-R4 providing ... The policy states that the fusion procedure, which employs ...
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Kentucky blocked the sale of ...
Breaking Medicine Technology:VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... MISSISSAUGA, Ontario, March 11, 2011 Valeant Pharmaceuticals ... VRX) announced that effective March 10, 2011, the ... S.A. About Valeant Valeant Pharmaceuticals ... pharmaceutical company that develops, manufactures and markets a ...
... (Nasdaq: OPTR ) today announced 2010 fourth quarter ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO ) Optimer reported a ... of $11.9 million, or $0.31 per common share, as compared ... common share, for the same period in 2009.  Optimer reported ...
Cached Medicine Technology:Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 2Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 3Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 4Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 5Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 6Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 7Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results 8
(Date:8/21/2014)... 2014 American Addiction Centers, a leading ... individuals with drug and/or alcohol addiction, has been named ... Private Companies. , The company is ranked 7th on ... and 4th on the list in the “Nashville Metro ... 995%, American Addiction Centers (AAC) ascended to number 474 ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Sasha is a ... dog. Sasha is getting a little older, and is having ... But Sasha just happens to have an owner who purchased ... Judy had an accident, and could no longer get up ... to her finished basement. She had tried a stair ...
(Date:8/21/2014)... of Chest Physicians (CHEST) announces the immediate release ... During Pandemics and Disasters: CHEST Consensus Statement today ... CHEST while the global health-care community ... consensus statement aims to guide ethical decision-making, coordination ... The statement was developed by over 100 clinicians ...
(Date:8/21/2014)... NJ (PRWEB) August 21, 2014 ... leading Radiologists, Amish P. Patel, MD, and Sujoy ... system welcomes Dr. Patel and Dr. Menon to ... comprehensive array of diagnostic imaging services to patients ... Bayonne Medical Center, Christ Hospital and Hoboken University ...
(Date:8/21/2014)... SAN FRANCISCO, Aug. 21, 2014 Individuals with schizophrenia ... goals for themselves, and a new study from San ... difficulty in assessing the amount of effort required to ... published this week in the Journal of Abnormal ... deficits among patients with schizophrenia and help those patients ...
Breaking Medicine News(10 mins):Health News:American Addiction Centers Named to Inc. 500 List Recognition for Three-Year Sales Growth of 995% 2Health News:Sasha Gets a Butler Mobility Inclined Platform Lift 2Health News:CHEST releases new expert guidance in care of the critically ill and injured 2Health News:Two Top Radiologists Join CarePoint Health 2Health News:Difficulty assessing effort drives motivation deficits in schizophrenia, study finds 2
... possible genetic cause for increased risk for a ... that leads to shorter survival, according to data ... journal of the American Association for Cancer Research. ... and differences in colorectal cancer incidence, aggressiveness and ...
... N.C. A recent discovery by researchers at Wake Forest ... new drug that inhibits tumor growth in cancer patients and ... discovery stems from a study, recently published in the ... United States of America, in which researchers looked at angiogenesis ...
... 31 Rheumatoid arthritis (RA) is a systemic disease ... system attacks the joints through the thin layer of ... joints. The most visible symptoms of RA are swollen ... feet. It can cause fatigue, fever, loss of appetite ...
... it is recalling Kroger Lite Mayo in 32-ounce plastic jars with ... Southwestern Ohio, including Cincinnati and Dayton, and in Northern Kentucky and ... illnesses have been reported in connection with the product. Kroger is ... , Kroger Lite Mayo sold ...
... As the United States prepares to reduce troop ... as 4.7 million displaced civilians in the region remain at ... strategy for addressing Iraq,s socioeconomic needs.In prepared remarks delivered Tuesday ... and South Asia, International Medical Corps President & CEO Nancy ...
... Corporation (NYSE: PRA ) announced today that the ... (PICA) have overwhelmingly approved the sponsored demutualization that will bring ... as a standalone subsidiary. The transaction, which requires final regulatory approval ... Illinois , is expected to close early in the second ...
Cached Medicine News:Health News:Blood protein may hold key to stopping tumor growth in cancer patients 2Health News:Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia 2Health News:Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia 3Health News:In Testimony before Senate, International Medical Corps CEO Urges U.S. to Increase Support for Displaced Iraqis 2Health News:PICA Policyholders Approve ProAssurance Transaction 2Health News:PICA Policyholders Approve ProAssurance Transaction 3Health News:PICA Policyholders Approve ProAssurance Transaction 4Health News:PICA Policyholders Approve ProAssurance Transaction 5Health News:PICA Policyholders Approve ProAssurance Transaction 6
Albarran double-horn bridge for use with sheaths from 20-25 Fr and designed for accurate articulation of flexible devices....
... and removal in the urinary tract. The nitinol ... shape following extreme torsion. The unique tipless design ... basket to open at the base of the ... reduces the likelihood of mucosal damage and perforation. ...
Bard Coude-Tip Latex Urethral Catheter, Two Eyes (Tiemann Model)...
Red Latex Bardex I.C. Foley 2-Way Catheter (Council Model)...
Medicine Products: